Influence of interleukin-2 deficiency on the generation of autoimmune B cells.
暂无分享,去创建一个
[1] F. Mackay,et al. B cells and the BAFF/APRIL axis: fast-forward on autoimmunity and signaling. , 2007, Current opinion in immunology.
[2] P. Youinou. B cell conducts the lymphocyte orchestra. , 2007, Journal of autoimmunity.
[3] K. Pattanapanyasat,et al. The role of disease stage, plasma viral load and regulatory T cells (Tregs) on autoantibody production in SIV-infected non-human primates. , 2007, Journal of autoimmunity.
[4] S. Ju,et al. Novel animal models for Sjögren's syndrome: expression and transfer of salivary gland dysfunction from regulatory T cell-deficient mice. , 2006, Journal of autoimmunity.
[5] Ronald N Germain,et al. Stromal cell networks regulate lymphocyte entry, migration, and territoriality in lymph nodes. , 2006, Immunity.
[6] I. Mackay,et al. IL-2 receptor alpha deficiency and features of primary biliary cirrhosis. , 2006, Journal of autoimmunity.
[7] Xiangdong Lu,et al. Autoreactive MZ and B-1 B-cell activation by Faslpr is coincident with an increased frequency of apoptotic lymphocytes and a defect in macrophage clearance. , 2006, Blood.
[8] L. Morel,et al. Role of B-1a cells in autoimmunity. , 2006, Autoimmunity reviews.
[9] G. Tsokos,et al. Transcriptional repression of interleukin-2 in human systemic lupus erythematosus. , 2006, Autoimmunity reviews.
[10] S. Nish,et al. CD4+CD25+ Regulatory T Cells Inhibit the Maturation but Not the Initiation of an Autoantibody Response1 , 2005, The Journal of Immunology.
[11] S. Nish,et al. The Influence of Effector T Cells and Fas Ligand on Lupus-Associated B Cells 1 , 2005, The Journal of Immunology.
[12] M. Bergman,et al. The Enlarged Population of Marginal Zone/CD1dhigh B Lymphocytes in Nonobese Diabetic Mice Maps to Diabetes Susceptibility Region Idd111 , 2005, The Journal of Immunology.
[13] J. Erikson,et al. The regulation and activation of lupus‐associated B cells , 2005, Immunological reviews.
[14] S. Nish,et al. CD4 CD25 Regulatory T Cells Inhibit the Maturation but Not the Initiation of an Autoantibody Response , 2005 .
[15] J. Cyster,et al. Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs. , 2005, Annual review of immunology.
[16] R. Proia,et al. Sphingosine 1-phosphate receptor 1 promotes B cell localization in the splenic marginal zone , 2004, Nature Immunology.
[17] J. Cyster,et al. Requirements for Follicular Exclusion and Competitive Elimination of Autoantigen-Binding B Cells1 , 2004, The Journal of Immunology.
[18] M. Nolte,et al. A Conduit System Distributes Chemokines and Small Blood-borne Molecules through the Splenic White Pulp , 2003, The Journal of experimental medicine.
[19] M. Weigert,et al. Anti–DNA B Cells in MRL/lpr Mice Show Altered Differentiation and Editing Pattern , 2002, The Journal of experimental medicine.
[20] F. Finkelman,et al. The impact of T helper and T regulatory cells on the regulation of anti-double-stranded DNA B cells. , 2002, Immunity.
[21] M. Weigert,et al. Autoreactive B Cells in the Marginal Zone that Express Dual Receptors , 2002, The Journal of experimental medicine.
[22] S. Clarke,et al. Low-Affinity Anti-Smith Antigen B Cells Are Regulated by Anergy as Opposed to Developmental Arrest or Differentiation to B-11 , 2002, The Journal of Immunology.
[23] R. Sartor,et al. Disrupted B‐lymphocyte development and survival in interleukin‐2‐deficient mice , 2001, Immunology.
[24] C. Grimaldi,et al. Cutting Edge: Expansion and Activation of A Population of Autoreactive Marginal Zone B Cells in a Model of Estrogen-Induced Lupus , 2001, The Journal of Immunology.
[25] J. Cyster,et al. Coexpression of the chemokines ELC and SLC by T zone stromal cells and deletion of the ELC gene in the plt/plt mouse. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[26] R. Hardy,et al. Functional Consequences of the Developmental Arrest and Follicular Exclusion of Anti-Double-Stranded DNA B Cells1 , 2000, The Journal of Immunology.
[27] F. Huang,et al. Modulation of autoimmune disease in the MRL-lpr/lpr mouse by IL-2 and TGF-β1 gene therapy using attenuated Salmonella typhimurium as gene carrier , 1999, Lupus.
[28] E. L. Prak,et al. Editing disease-associated autoantibodies. , 1997, Immunity.
[29] F. Alt,et al. Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. , 1995, Immunity.
[30] H. Griesser,et al. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta. , 1995, Science.
[31] A. Aruffo,et al. Characterization and cloning of a novel glycoprotein expressed by stromal cells in T-dependent areas of peripheral lymphoid tissues , 1992, The Journal of experimental medicine.
[32] I. Horak,et al. Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting , 1991, Nature.
[33] A. Heimberger,et al. Induction by antigen of intrathymic apoptosis of CD4+CD8+TCRlo thymocytes in vivo. , 1990, Science.